Skip to main content
AVLS Congress and UIP 2023 World Congress Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream Session
Live Stream Session
Ticketed Event
Ticketed Event
Invitation Only
Invitation Only
Translation
Translation
Recorded Content
Recorded Content
CME
CME
Non-CME
Non-CME
Back
Watch Recording

International

Connecting the World: Venous Disease with the Mexican Societies

Tuesday, September 19, 2023
2:30 PM – 4:00 PM US EDT
Location: 235/236/237
Earn 1.5 CME hour(s)
discuss the role of the different venoactive medications and elastic compression during the periprocedural period when treating varicose veins. is there evidence in favor or against their routine use. and what is the expected effect.

Session of the Mexican Societies: Mexican Academy of Phlebology and Lymphology (AMFyL); Mexican Society of Angiology, Vascular and Endovascular Surgery (SMACVE); Mexican Venous Forum (FVM); Mexican College of Phlebology (CMCJRT); Hendolat Veins (HV).

Learning Objectives:

  • Upon completion, participants will be able to combine de treatment.
  • Upon completion, participants will be able to use de venoactive drugs.
  • Upon completion, participants will be able to assess the patients in compression therapy.
  • Upon completion, participants will be able to decide between thermal or non-thermal treatments.
  • Upon completion, participants will be able to determine the role of perforator veins.

    Program Chair(s)

  • Javier A. Serralde Gallegos, Sr. (he/him/his)

    President / Phlebology and Lymphology
    Mexican Academy of Phlebology and Lymphology
    Instituto Politécnico Nacional
    Coyoacán, Distrito Federal, Mexico

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    • Co-Chair(s)

  • Alejandro J. Gonzalez Ochoa, MD

    Venous Committee
    Sociedad Mexicana Angiologia y Cirugia Vascular, Society Vascular Surgery,
    San Luis Rio Colorado, Sonora, Mexico

    Disclosure(s): Alfasigma: Consultant/Advisory Board, Research Grant; Servier: Consultant/Advisory Board

  • Sergio Gianesini, MD, PhD, FACS

    UIP President-Elect
    University of Ferrara
    USUHS University
    rovigo, Veneto, Italy

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.